E-LIB Suche - Ergebnisse für: Fumoleau, P.

1

Delayed care for patients with newly diagnosed cancer due t..:

Blay, J.Y. ; Boucher, S. ; Le Vu, B....
ESMO Open. 6 (2021) 3 - p. 100134 , 2021

Link: https://doi.org/10.1016/..

2

Pattern of breast cancer blood flow and metabolism, assesse..:

Lasserre, M. ; Humbert, O. ; Bertaud, A....
Médecine Nucléaire. 42 (2018) 3 - p. 133 , 2018

Link: https://doi.org/10.1016/..

3

Impact de l'aprépitant sur le risque d'encéphalopathie sous..:

Arcizet, J. ; Schmitt, A. ; Coudert, B....
Le Pharmacien Hospitalier et Clinicien. 52 (2017) 1 - p. e24 , 2017

Link: https://doi.org/10.1016/..

4

Predictive factors of pathologic complete response of HER2-..:

Jankowski, Clémentine ; Guiu, S. ; Cortet, M....
Breast Cancer Research and Treatment. 161 (2016) 1 - p. 73-81 , 2016

Link: https://doi.org/10.1007/..

5

A Loss of Chance Index: a New Tool for Optimizing Patient A..:

Gavini, F ; Sarkozy, F ; Jouan-Flahault, C.
Value in Health. 18 (2015) 7 - p. A476 , 2015

Link: https://doi.org/10.1016/..

6

Identification de biomarqueurs prédictifs de la réponse des..:

Humbert, O. ; Riedinger, J.M. ; Charon-Barra, C....
Médecine Nucléaire. 39 (2015) 3 - p. 215-216 , 2015

Link: https://doi.org/10.1016/..

7

HER2-positivity rates in breast cancer: no variation over t..:

Beltjens, F. ; Bertaut, A. ; Pigeonnat, S....
European Journal of Cancer Care. 26 (2015) 2 - p. e12404 , 2015

Link: https://doi.org/10.1111/..

8

Valeur pronostique de la réponse métabolique en TEP-FDG des..:

Depardon, E. ; Kanoun, S. ; Humbert, O....
Médecine Nucléaire. 39 (2015) 3 - p. 257 , 2015

Link: https://doi.org/10.1016/..

9

Impact of neoadjuvant chemotherapy on survival in breast ca..:

Dabakuyo, T.S. ; Arnaud, A. ; Maingon, P....
European Journal of Cancer Care. 22 (2013) 5 - p. 638-647 , 2013

Link: https://doi.org/10.1111/..

10

Phase I and pharmacokinetic study of IV vinflunine in cance..:

Delord, J. P. ; Ravaud, A. ; Bennouna, J....
Investigational New Drugs. 31 (2012) 3 - p. 724-733 , 2012

Link: https://doi.org/10.1007/..

11

Appropriate cytotoxic drugs usages in solid tumors: Impact ..:

Lochard-Lefrancois, A. ; Blandin, A.-C. ; Fagnoni, P....
Le Pharmacien Hospitalier et Clinicien. 47 (2012) 2 - p. e1-e7 , 2012

Link: https://doi.org/10.1016/..

12

Bon usage des anticancéreux dans les tumeurs solides : impa..:

Lochard-Lefrancois, A. ; Blandin, A.-C. ; Fagnoni, P....
Le Pharmacien Hospitalier et Clinicien. 47 (2012) 1 - p. 30-36 , 2012

Link: https://doi.org/10.1016/..

13

522 Preclinical Evaluation of Indium 111 Radiolabeled Trast..:

Oudot, A. ; Collin, B. ; Raguin, O....
European Journal of Cancer. 48 (2012) - p. 161 , 2012

Link: https://doi.org/10.1016/..

14

Neoadjuvant therapy for breast cancer has no benefits on ov..:

Le Ray, I. ; Dabakuyo, S. ; Crehange, G....
European Journal of Cancer. 48 (2012) 15 - p. 2300-2310 , 2012

Link: https://doi.org/10.1016/..

15

A phase I study of vinflunine in combination with capecitab..:

Campone, M. ; Isambert, N. ; Bourbouloux, E....
Cancer Chemotherapy and Pharmacology. 69 (2011) 4 - p. 871-879 , 2011

Link: https://doi.org/10.1007/..